United States · FDA National Drug Code directory
ZERBAXA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67919-030_23d9b7be-abf3-4ca6-bce8-d80643a708e7
- Product NDC
- 67919-030
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- ceftolozane and tazobactam
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20141219
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFTOLOZANE SULFATE — 1 g/10mL
- TAZOBACTAM SODIUM — .5 g/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (67919-030-01) / 10 mL in 1 VIAL, SINGLE-DOSE · 67919-030-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →